|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Carney DN and Hansen HH: Non-small-cell
lung cancer - stalemate or progress? N Engl J Med. 343:1261–1262.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bröker LE and Giaccone G: The role of new
agents in the treatment of non-small cell lung cancer. Eur J
Cancer. 38:2347–2361. 2002.
|
|
5
|
Yang CS, Wang H and Hu B: Combination of
chemopreventive agents in nanoparticles for cancer prevention.
Cancer Prev Res (Phila). 6:1011–1014. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roth BL, Sheffler DJ and Kroeze WK: Magic
shotguns versus magic bullets: selectively non-selective drugs for
mood disorders and schizophrenia. Nat Rev Drug Discov. 3:353–359.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu S, Zhao Y, Zhao YX and Long D:
Influence of maintenance therapy of shenyi capsule on survival of
advanced non-small cell lung cancer patients after chemotherapy.
Journal of Guangzhou University of Traditional Chinese Medicine.
30:337–340. 2013.(In Chinese).
|
|
8
|
Wang CZ, Calway T and Yuan CS: Herbal
medicines as adjuvants for cancer therapeutics. Am J Chin Med.
40:657–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Konkimalla VB and Efferth T:
Evidence-based Chinese medicine for cancer therapy. J
Ethnopharmacol. 116:207–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li XL and Li HR: Three factors ‘toxicity,
blood stasis, cold congealing’ for pathogenesis exploring of tumor
metastasis. China Journal of Traditional Chinese Medicine and
Pharmacy. 21:440–441. 2006.(In Chinese).
|
|
11
|
Han GX and Feng JZ: Application of xiao
chai hu tang in preventing and treating cancer. Zhejiang Journal of
Traditional Chinese Medicine. 4:687–688. 2010.(In Chinese).
|
|
12
|
Liao HF, Lu MC, Chang HC, Wei CC, Kao CH,
Chen ZH, Huang CC and Li C: Effects of herbal medicinal formulas on
suppressing viral replication and modulating immune responses. Am J
Chin Med. 38:173–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Xie M and Gan Y: Effect of
Xiaochaihu decoction and different herbal formulation of component
on inhibiting H22 liver cancer in mice and enhancing immune
function. Zhongguo Zhong Yao Za Zhi. 33:1039–1044. 2008.(In
Chinese).
|
|
14
|
Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH,
Huang SP and Liu XX: Computational approaches for exploring the
potential synergy and polypharmacology of Duhuo Jisheng Decoction
in the therapy of osteoarthritis. Mol Med Rep. 7:1812–1818.
2013.PubMed/NCBI
|
|
15
|
Gu J, Zhang H, Chen L, Xu S, Yuan G and Xu
X: Drug-target network and polypharmacology studies of a
Traditional Chinese Medicine for type II diabetes mellitus. Comput
Biol Chem. 35:293–297. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiao X, Hou T, Zhang W, Guo S and Xu X: A
3D structure database of components from Chinese traditional
medicinal herbs. J Chem Inf Comput Sci. 42:481–489. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou JX, Xie GR and Yang XD: Handbook of
the Constituents in Chinese Herb Original Plants. Chemical Industry
Press; Beijing: pp. 1165–1211. 2004, (In Chinese).
|
|
18
|
Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F,
Zhang L, Song Y, Liu X, Zhang J, et al: Therapeutic target database
update 2012: a resource for facilitating target-oriented drug
discovery. Nucleic Acids Res. 40(Database issue): D1128–D1136.
2012.PubMed/NCBI
|
|
19
|
Venkatachalam CM, Jiang X, Oldfield T and
Waldman M: LigandFit: a novel method for the shape-directed rapid
docking of ligands to protein active sites. J Mol Graph Model.
21:289–307. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Montes M, Braud E, Miteva MA, Goddard ML,
Mondésert O, Kolb S, Brun MP, Ducommun B, Garbay C and Villoutreix
BO: Receptor-based virual ligand screening for the identification
of novel CDC25 phosphatase inhibitors. J Chem Inf Model.
48:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: new features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su G, Kuchinsky A, Morris JH, States DJ
and Meng F: GLay: community structure analysis of biological
networks. Bioinformatics. 26:3135–3137. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lipinski CA, Lombardo F, Dominy BW and
Feeney PJ: Experimental and computational approaches to estimate
solubility and permeability in drug discovery and development
settings. Adv Drug Deliv Rev. 46:3–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carmady B and Smith CA: Use of Chinese
medicine by cancer patients: a review of surveys. Chin Med.
6:222011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dobson CM: Chemical space and biology.
Nature. 432:824–828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun ML and Zeng BR: Anti-tumor clinical
application of Xiaochaihu-tang and the progress of experimental
study on its disassembled prescriptions. Hunan Journal of
Traditional Chinese Medicine. 29(4): 134–136. 2013.(In
Chinese).
|
|
27
|
Yang JY, Li YZ, Fan ZW, Zheng SM and Xu
JZ: Clinical application overview of Xiaochaihu-tang. Chinese
Medicine Modern Distance Education of China. 9(9): 74–75. 2011.(In
Chinese).
|
|
28
|
Chan JY, Tan BK and Lee SC: Scutellarin
sensitizes drug-evoked colon cancer cell apoptosis through enhanced
caspase-6 activation. Anticancer Res. 29:3043–3047. 2009.PubMed/NCBI
|
|
29
|
Xu H and Zhang S: Scutellarin-induced
apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3
pathway. Phytother Res. 27:1524–1528. 2013.PubMed/NCBI
|
|
30
|
Franek KJ, Zhou Z, Zhang WD and Chen WY:
In vitro studies of baicalin alone or in combination with Salvia
miltiorrhiza extract as a potential anti-cancer agent. Int J
Oncol. 26:217–224. 2005.PubMed/NCBI
|
|
31
|
Nagaprashantha LD, Vatsyayan R, Singhal J,
Fast S, Roby R, Awasthi S and Singhal SS: Anti-cancer effects of
novel flavonoid vicenin-2 as a single agent and in synergistic
combination with docetaxel in prostate cancer. Biochem Pharmacol.
82:1100–1109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohno H, Araho D, Uesawa Y, Kagaya H,
Ishihara M, Sakagami H and Yamamoto M: Evaluation of cytotoxicity
and tumor-specificity of licorice flavonoids based on chemical
structure. Anticancer Res. 33:3061–3068. 2013.PubMed/NCBI
|
|
33
|
Kinghorn AD, Su BN, Jang DS, Chang LC, Lee
D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ, et al:
Natural inhibitors of carcinogenesis. Planta Med. 70:691–705. 2004.
View Article : Google Scholar
|
|
34
|
Broxterman HJ and Georgopapadakou NH:
Anticancer therapeutics: ‘Addictive’ targets, multi-targeted drugs,
new drug combinations. Drug Resis Updat. 8:183–197. 2005.
|
|
35
|
Shoshan MC and Linder S: Promiscuous and
specific anti-cancer drugs: combatting biological complexity with
complex therapy. Cancer Ther. 2:297–304. 2004.
|
